These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

917 related items for PubMed ID: 20012863

  • 21. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 22. Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead.
    Meli M, Pennati M, Curto M, Daidone MG, Plescia J, Toba S, Altieri DC, Zaffaroni N, Colombo G.
    J Med Chem; 2006 Dec 28; 49(26):7721-30. PubMed ID: 17181154
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.
    Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV.
    Cell Death Differ; 2006 Sep 28; 13(9):1434-41. PubMed ID: 16311509
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
    Walsby EJ, Lazenby M, Pepper CJ, Knapper S, Burnett AK.
    Br J Haematol; 2013 Apr 28; 161(1):57-67. PubMed ID: 23356405
    [Abstract] [Full Text] [Related]

  • 29. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA, Lupu R.
    Int J Mol Med; 2005 Jan 28; 15(1):33-40. PubMed ID: 15583825
    [Abstract] [Full Text] [Related]

  • 30. Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma.
    Francis LK, Alsayed Y, Leleu X, Jia X, Singha UK, Anderson J, Timm M, Ngo H, Lu G, Huston A, Ehrlich LA, Dimmock E, Lentzsch S, Hideshima T, Roodman GD, Anderson KC, Ghobrial IM.
    Clin Cancer Res; 2006 Nov 15; 12(22):6826-35. PubMed ID: 17121904
    [Abstract] [Full Text] [Related]

  • 31. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
    Phillips PA, Dudeja V, McCarroll JA, Borja-Cacho D, Dawra RK, Grizzle WE, Vickers SM, Saluja AK.
    Cancer Res; 2007 Oct 01; 67(19):9407-16. PubMed ID: 17909050
    [Abstract] [Full Text] [Related]

  • 32. [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].
    Li X, Deng HY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar 01; 39(2):181-3. PubMed ID: 18630678
    [Abstract] [Full Text] [Related]

  • 33. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.
    Lee JH, Li YC, Ip SW, Hsu SC, Chang NW, Tang NY, Yu CS, Chou ST, Lin SS, Lino CC, Yang JS, Chung JG.
    Anticancer Res; 2008 Mar 01; 28(3A):1701-11. PubMed ID: 18630529
    [Abstract] [Full Text] [Related]

  • 34. Hsp90 inhibitors sensitise human colon cancer cells to topoisomerase I poisons by depletion of key anti-apoptotic and cell cycle checkpoint proteins.
    McNamara AV, Barclay M, Watson AJ, Jenkins JR.
    Biochem Pharmacol; 2012 Feb 01; 83(3):355-67. PubMed ID: 22138446
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cells.
    Nakashima T, Ishii T, Tagaya H, Seike T, Nakagawa H, Kanda Y, Akinaga S, Soga S, Shiotsu Y.
    Clin Cancer Res; 2010 May 15; 16(10):2792-802. PubMed ID: 20406843
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells.
    Radanyi C, Le Bras G, Marsaud V, Peyrat JF, Messaoudi S, Catelli MG, Brion JD, Alami M, Renoir JM.
    Cancer Lett; 2009 Feb 08; 274(1):88-94. PubMed ID: 18842335
    [Abstract] [Full Text] [Related]

  • 39. Discovery and biological activity of 6BrCaQ as an inhibitor of the Hsp90 protein folding machinery.
    Audisio D, Messaoudi S, Cegielkowski L, Peyrat JF, Brion JD, Methy-Gonnot D, Radanyi C, Renoir JM, Alami M.
    ChemMedChem; 2011 May 02; 6(5):804-15. PubMed ID: 21374821
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H.
    Ann Surg Oncol; 2009 Mar 02; 16(3):761-71. PubMed ID: 19116755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.